Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov 24:22:701-706.
doi: 10.12659/aot.906236.

Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus

Hisamitsu Miyaaki  1 , Mitsuhisa Takatsuki  2 , Tatsuki Ichikawa  1 , Masaaki Hidaka  2 , Akihiko Soyama  2 , Hideki Ohdan  3 , Yukihiro Inomata  4 , Shinji Uemoto  5 , Norihiro Kokudo  6 , Kazuhiko Nakao  7 , Susumu Eguchi  2
Affiliations

Intrahepatic MicroRNA Profile of Liver Transplant Recipients with Hepatitis C Virus Co-Infected with Human Immunodeficiency Virus

Hisamitsu Miyaaki et al. Ann Transplant. .

Abstract

BACKGROUND In patients with human immunodeficiency virus (HIV) and hepatitis C virus (HCV) co-infection, HIV can modulate HCV replication and immune response as well as accelerate liver fibrosis. The role of miRNA in HIV/HCV co-infection is not fully elucidated. The aim of this study was to examine the differential expression of miRNAs in the liver. MATERIAL AND METHODS Thirteen patients who had undergone a liver transplant (7 HCV-infected and 6 HIV/HCV-co-infected patients) were examined using a miRNA array containing 1347 human miRNAs. To confirm the microarray results, data for 20 patients (10 HCV-infected and 10 HIV/HCV-co-infected) were validated using real-time polymerase chain reaction probing for miR101b, miR149, and miR200c. This miRNA was selected based on microarray results and its biological significance in liver fibrosis. RESULTS Microarray analysis revealed 22 miRNAs that were differentially expressed in the HIV/HCV-co-infected group compared to the HCV-infected group (p<0.05). The expression of miR-101b and miR149 was significantly decreased in the HIV/HCV-co-infected group compared to that in the HCV-infected group (miR101b, 0.103±0.09 vs. 0.0157±0.0093, p=0.007; miR149, 0.152±0.159 vs. 0.0192±0.015, p=0.025). CONCLUSIONS HIV/HCV co-infection may promote liver fibrosis by modulating miRNA expression.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Differentially expressed miRNAs in HIV/HCV-co-infected and HCV-infected patients. Red indicates higher miRNA expression and green indicates lower miRNA expression.
Figure 2
Figure 2
(A) Data are presented as mean ± standard deviation (SD). The expression of miR-101 was significantly decreased in the HIV/HCV-co-infected group (n=10) as compared to that in the HCV-infected group (n=10) (0.103±0.09 vs. 0.0157±0.0093, p=0.007, Student’s t test.). (B) Data are presented as mean ±SD. The expression of miR-149 decreased significantly in the HIV/HCV-co-infected group (n=10) as compared to that in the HCV-infected group (n=10) (0.152±0.159 vs. 0.0192±0.015, p=0.025, Student’s t test).
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–62. - PubMed
    1. Sherman KE, Rouster SD, Chung RT, Rajicic N. Hepatitis C Virus prevalence among patients infected with Human Immunodeficiency Virus: A cross-sectional analysis of the US adult AIDS Clinical Trials Group. Clin Infect Dis. 2002;34:831–37. - PubMed
    1. Lohse N, Hansen AB, Pedersen G, et al. Survival of persons with and without HIV infection in Denmark, 1995–2005. Ann Intern Med. 2007;146:87–95. - PubMed
    1. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: Recent estimates and future implications. Curr Opin Infect Dis. 2013;26:17–25. - PubMed
    1. de Ledinghen V, Barreiro P, Foucher J, et al. Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy. J Viral Hepat. 2008;15:427–33. - PubMed

MeSH terms